Latest Entry: @ MarkLevinShow - Bull without a horn; 45 without bullets; Paul Revere without a horse     Latest Comments: Talk Back Here

Topic: Clinical Pharmacology


Britain tests first Cannabis related medicine for rheumatoid arthritis (November 13, 2005)
Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma (May 26, 2005)
Cystatin C May Push Creatinine Off Risk Radar (May 19, 2005)
Cancer Treatment Success Stuns Scientists (May 16, 2005)
Antibody, cancer drug combo shows promise against breast tumors (May 16, 2005)
USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) (May 2, 2005)
Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer (April 26, 2005)
Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center (April 21, 2005)
Traditional Medicine Derivatives Kill Cancer Cells (April 20, 2005)
Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds (April 19, 2005)
Avastin (Bevacizumab, rhuMAb-VEGF) Plus Chemotherapy Appears to Produce Significant Benefit in First-Line Metastatic Breast Cancer (April 18, 2005)
Report on Meta-analysis of "Effectiveness of anti-anemia drug in treatment of cancer patients" (April 8, 2005)
Drug to be tested for breast-cancer prevention (April 4, 2005)
Compound Blocks Known Cancer-Causing Protein (March 22, 2005)
Prostate Cancer - Ferring's degarelix shows immediate onset of action and sustained activity (March 21, 2005)
Avonex Linked to Rare Reports of Severe Hepatic Injury, Failure (March 19, 2005)
Rare Infection Is Confirmed in 2nd Patient on M.S. Drug Tysabri (March 5, 2005)
Multiple Sclerosis Drug Tysabri Pulled Off Market (February 28, 2005)
Green Tea Extract Has Potential as Anti-Cancer Agent, According to UCLA Researchers (February 15, 2005)
FDA Says Adderall Drug Data Isn't Enough for Recall (February 11, 2005)
Liver alert on hyperactivity drug Strattera (February 3, 2005)
New drug hope for breast cancer patients (January 27, 2005)
Beware of grapefruit juice with your medications (January 18, 2005)
Drug Reduces Frequency of MS Relapses (January 16, 2005)
Antibiotics 'block nerve damage' (January 6, 2005)
Smart bombs developed to target cancer tumours (January 6, 2005)
Arthritis Medicines and Cardiovascular Events--"House of Coxibs" (January 6, 2005)
Potential Deadly Side-effects of Prozac: Medical journal turns missing murder case documents over to FDA (December 31, 2004)
Suit: Children's Motrin has side effects (December 29, 2004)
COX-2 Inhibitors: A CLASS Act or Just VIGORously Promoted (December 25, 2004)
Early research - taxanes for Alzheimer's? (December 22, 2004)
Naproxen in the firing line! (December 22, 2004)
NEJM early release correspondence regarding valdecoxib (Bextra) (December 21, 2004)
Genaissance Identifies Genetic Markers Implicated In Fatal Side Effects Of Schizophrenia Drug (December 20, 2004)
Cardiovascular risk and COX-2 inhibition in rheumatological practice. (December 19, 2004)
FDA Approvals: Omacor, Nuflexxa, Combunox, and Others (December 16, 2004)
LUNDBECK SAYS ALZHEIMER'S DRUG APPROVED IN CANADA (December 10, 2004)
Bextra to have new warnings, says FDA (December 10, 2004)
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. (December 2, 2004)
Study: Drug helps sickest cancer patients (November 30, 2004)
Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma. (November 29, 2004)
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. (November 29, 2004)
Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future? (November 29, 2004)
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis. (November 29, 2004)
Transdermal fentanyl (Duragesic): respiratory arrest in adolescents (November 28, 2004)
FDA GRANTS ACCELERATED APPROVAL OF TYSABRI FOR MS (November 28, 2004)
Bayer's Baycol Should Have Been Withdrawn Earlier (November 27, 2004)
FDA Acts to Remove Ephedra-Containing Dietary Supplements From Market - What took so long? (November 27, 2004)
Why Aren't Amiodarone's fatal side effects labeled? (November 26, 2004)
On New Medicines and Drug Safety, Comments and the Story (November 26, 2004)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. (November 26, 2004)
Selective Serotonin Reuptake Inhibitors May Increase Risk of Abnormal Bleeding CME (November 26, 2004)
The Effect Of Gemfibrozil On The Pharmacokinetics of Rosuvastatin. (November 24, 2004)
Eradication of multi-drug resistant Acinetobacter from an intensive care unit. (November 22, 2004)
Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma. (November 21, 2004)
Pfizer Statement Regarding Additional Prescribing Information for Depo-Provera (November 21, 2004)
Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002 (November 18, 2004)
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. (November 18, 2004)
Disturbance of vision by COX-2 inhibitors (November 18, 2004)
Sonic Hedgehog shapes the brain (November 17, 2004)
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. (November 17, 2004)
Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition (November 17, 2004)
Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities. (November 16, 2004)
The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. (November 16, 2004)
COX-2 Inhibition And Cancer: Experimental Findings And Clinical Correlates. (November 16, 2004)
Adverse Reactions to Biological Modifiers (November 15, 2004)
FDA Medwatch Alert On Mifeprex (November 15, 2004)
Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report. (November 15, 2004)
The Immunotherapy of Alzeimer's Disease (November 15, 2004)
A study of the Effectiveness of Commercially Available Drink Test Coasters for the Detection of "Date Rape" Drugs in Beverages. (November 14, 2004)
Upper Gastrointestinal Adverse Drug Reactions And Cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib) (November 13, 2004)
Access Cardiosystems, Inc. Issues a Worldwide Recall of Automated External Defibrillators (AED'S) (November 12, 2004)
FDA Alert For Actra-Rx and Yilishen Dietary Supplements (November 10, 2004)
Suspected Interaction Between Tramadol and Warfarin (November 10, 2004)
FDA Indicates Vioxx Might Have Contributed to About 27K Heart Attacks, Deaths (November 3, 2004)